1. Introduction {#sec1-molecules-24-00069}
===============

We carried out systematic phytochemical screenings of the plants belonging to the family *Ranunculaceae*, such as the *Adonis* \[[@B1-molecules-24-00069],[@B2-molecules-24-00069],[@B3-molecules-24-00069],[@B4-molecules-24-00069]\], *Anemone* \[[@B5-molecules-24-00069],[@B6-molecules-24-00069]\], *Cimicifuga* \[[@B7-molecules-24-00069],[@B8-molecules-24-00069]\], *Clematis* \[[@B9-molecules-24-00069]\], *Helleborus* \[[@B10-molecules-24-00069],[@B11-molecules-24-00069],[@B12-molecules-24-00069],[@B13-molecules-24-00069],[@B14-molecules-24-00069]\], and *Pulsatilla* species \[[@B15-molecules-24-00069],[@B16-molecules-24-00069]\], and isolated various triterpene and steroidal glycosides, including cardiac and pregnane glycosides. Among them, cycloartane glycosides had a unique structure and showed relationships between chemical structure and cytotoxic activity \[[@B8-molecules-24-00069]\]. The genus *Eranthis* also belongs to the family *Ranunculaceae* and is taxonomically related to the genus *Helleborus* \[[@B17-molecules-24-00069]\]. Previously, we have isolated two new oleanane bisdesmosides, eranthisaponins A and B \[[@B18-molecules-24-00069]\], and eight new chromone derivatives from the tubers of *Eranthis cilicica* \[[@B19-molecules-24-00069]\]. Further phytochemical examination of the *E. cilicica* tubers resulted in the isolation of eleven new cycloartane glycosides and one new oleanane glycoside, together with one known oleanane glycoside. We report herein the structural determination of the new compounds by extensive spectroscopic analysis, including two-dimensional (2D) NMR, and enzymatic hydrolysis, followed by either X-ray crystallographic or chromatographic analysis. As part of our ongoing phytochemical study of *Ranunculaceae* plants, the cytotoxic activity of the cycloartane-type glycosides **2** and **8**, the aglycone **1a** and its C-23 epimer **8a**, and the oleanane-type triterpene glycosides **12** and **13** against HL-60 human promyelocytic leukemia cells is evaluated and briefly discussed.

2. Results and Discussion {#sec2-molecules-24-00069}
=========================

2.1. Isolation and Structure Elucidation of 1--13 {#sec2dot1-molecules-24-00069}
-------------------------------------------------

The MeOH extract of the *E. cilicica* tubers was allowed to pass through the porous-polymer polystyrene resin (Diaion HP-20) column, and a series of chromatographic separations of the glycoside-enriched fraction using column chromatography (CC) on silica gel and octadecylsilanized (ODS) silica gel were performed to obtain compounds **1**--**13** ([Figure 1](#molecules-24-00069-f001){ref-type="fig"}). The known compound **12** was identified as 3β-\[(*O*-β-[d]{.smallcaps}-glucopyranosyl-(1→4)-*O*-\[α-[l]{.smallcaps}-rhamnopyranosyl-(1→2)\]-α-[l]{.smallcaps}-arabinopyranosyl)oxy\]-23-hydroxyolean-12-en-28-oic acid by direct comparison with an authentic sample isolated from *Anemone coronaria* \[[@B6-molecules-24-00069]\].

Compound **1** was obtained as an amorphous solid, and its molecular formula was determined to be C~36~H~56~O~10~, based on high-resolution (HR)-electrospray ionization (ESI)-time-of-flight (TOF)-MS (*m*/*z* 671.3794 \[M + Na\]^+^) data and ^13^C-NMR spectrum with 36 carbon signals ([Table 1](#molecules-24-00069-t001){ref-type="table"}). The IR spectrum of **1** showed an absorption band attributed to hydroxy groups at 3388 cm^−1^. The ^1^H-NMR spectrum of **1** was typical of a triterpene glycoside based on a cycloartane derivative, showing signals for a cyclopropane methylene group at δ~H~ 0.48 and 0.20 (each d, *J* = 4.0 Hz); four tertiary methyl groups at δ~H~ 1.42, 1.36, 1.29, and 1.03 (each s); a secondary methyl group at δ~H~ 0.97 (d, *J* = 6.5 Hz); and an anomeric proton δ~H~ 4.94 (d, *J* = 7.8 Hz). Enzymatic hydrolysis of **1** using naringinase gave a new triterpene aglycone (**1a**: C~30~H~46~O~5~) as colorless needles and [d]{.smallcaps}-glucose as a carbohydrate moiety. Based on X-ray crystallographic analysis, the structure of **1a** was unambiguously established as (23*R*,24*R*,25*R*)-16β,23:23,26:24,25-triepoxy-9,19-cycloartane-3β,28-diol ([Figure 2](#molecules-24-00069-f002){ref-type="fig"}). Linkage of a β-[d]{.smallcaps}-glucopyranosyl group to the C-3 hydroxy group of the aglycone in **1** was ascertained by long-range correlations between the anomeric proton (H-1′) at δ~H~ 4.94 and the C-3 carbon of the aglycone at δ~C~ 88.6 in the ^1^H-detected heteronuclear multiple-bond connectivity (HMBC) spectrum of **1**. Thus, **1** was established as (23*R*,24*R*,25*R*)-16β,23:23,26:24,25-triepoxy-28-hydroxy-9,19-cycloartan-3β-yl β-[d]{.smallcaps}-glucopyranoside.

Compound **2** had the molecular formula C~42~H~66~O~15~, as determined by HR-ESI-TOF-MS (*m*/*z* 833.4297 \[M + Na\]^+^) and ^13^C-NMR (42 carbon signals) data. The molecular formula was larger than that of **1** by C~6~H~10~O~5~, which corresponded to one hexosyl unit. The ^1^H-NMR spectrum of **2** showed signals due to two anomeric protons at δ~H~ 5.20 (d, *J* = 7.9 Hz) and 4.87 (d, *J* = 7.8 Hz), as well as a cyclopropane methylene group at δ~H~ 0.47 and 0.20 (each d, *J* = 4.0 Hz), four tertiary methyl groups at δ~H~ 1.42, 1.35, 1.27, and 1.02 (each s), a secondary methyl group at δ~H~ 0.97 (d, *J* = 6.6 Hz). Enzymatic hydrolysis of **2** with naringinase gave **1a** and [d]{.smallcaps}-glucose. The ^1^H- and ^13^C-NMR signals of the diglycoside moiety, which were assigned based on ^1^H-^1^H correlation spectroscopy (COSY) and ^1^H-detected heteronuclear multiple coherence (HMQC) spectra, indicated the presence of a terminal β-[d]{.smallcaps}-glucopyranosyl unit \[δ~H~ 5.20 (d, *J* = 7.9 Hz, H-1′′ of Glc (II)); δ~C~ 104.9 (CH), 74.8 (CH), 78.2 (CH), 71.5 (CH), 78.4 (CH), 62.3 (CH~2~)\] and a C-4 glycosylated β-[d]{.smallcaps}-glucopyranosyl unit \[δ~H~ 4.87 (d, *J* = 7.8 Hz, H-1′ of Glc (I)); δ~C~ 106.4 (CH), 75.2 (CH), 76.9 (CH), 81.6 (CH), 76.2 (CH), 62.3 (CH~2~)\] in the molecule of **2 \[[@B20-molecules-24-00069]\]**. In the HMBC spectrum of **2**, long-range correlations were observed between H-1′′ of Glc (II) and C-3′ of Glc (I), and between H-1′ of Glc (I) and C-3 of the aglycone moiety at δ~C~ 88.7. The molecular formula of **2** was assigned as (23*R*,24*R*,25*R*)-16β,23:23,26:24,25-triepoxy-28-hydroxy-9,19-cylcoartan-3β-yl *O*-β-[d]{.smallcaps}-glucopyranosyl-(1→4)-β-[d]{.smallcaps}-glucopyranoside.

Compounds **3** and **4**, which had the same molecular formula as **2** (C~42~H~66~O~15~), gave **1a** and [d]{.smallcaps}-glucose upon enzymatic hydrolysis. The ^1^H- and ^13^C-NMR spectra of **3** and **4** suggested that they were constitutional isomers of **2** based on the linkage position of the terminal [d]{.smallcaps}-glucosyl unit (Glc (II)) at the inner [d]{.smallcaps}-glucosyl unit (Glc (I)) in the diglucosyl residue. In the HMBC spectrum of **3**, H-1′′ of Glc (II) at δ~H~ 5.28 (d, *J* = 7.9 Hz) showed a long-range correlation with C-3′ of Glc (I) at δ~C~ 88.7, and H-1′ of Glc (I) at δ~H~ 4.86 (d, *J* = 7.8 Hz), in turn, showed a long-range correlation with C-3 of the aglycone at δ~C~ 88.6. On the other hand, HMBC correlations were observed between H-1′′ of Glc (II) at δ~H~ 5.28 (d, *J* = 7.8 Hz) and C-6′ of Glc (I) at δ~C~ 70.2, and between H-1′ of Glc (I) at δ~H~ 4.86 (d, *J* = 7.7 Hz) and C-3 of the aglycone at δ~C~ 88.4 in **4**. Compounds **3** and **4** were established as *O*-β-[d]{.smallcaps}-glucopyranosyl-(1`→`3)-β-[d]{.smallcaps}-glucopyranoside and *O*-β-[d]{.smallcaps}-glucopyranosyl-(1`→`6)-β-[d]{.smallcaps}-glucopyranoside of (23*R*,24*R*,25*R*)-16β,23:23,26:24,25-triepoxy-28-hydroxy-9,19-cycloartan-3β-yl, respectively.

Compound **5** (C~48~H~76~O~20~) also yielded **1a** and [d]{.smallcaps}-glucose upon enzymatic hydrolysis. The ^1^H- and ^13^C-NMR spectra of **5** showed signals for two terminal β-[d]{.smallcaps}-glucopyranosyl units \[δ~H~ 5.45 (d, *J* = 7.9 Hz, H-1′′ of Glc (II)); δ~C~ 104.7 (CH), 75.1 (CH), 78.2 (CH), 71.6 (CH), 78.1 (CH), 62.3 (CH~2~); and δ~H~ 5.34 (d, *J* = 7.8 Hz, H-1′′′ of Glc (III)); δ~C~ 105.0 (CH), 75.1 (CH), 78.2 (CH), 71.5 (CH), 78.1 (CH), 62.5 (CH~2~)\] and a C-4 and C-6 diglycosylated β-[d]{.smallcaps}-glucopyranosyl unit \[δ~H~ 4.80 (d, *J* = 7.5 Hz, H-1′ of Glc (I)); δ~C~ 106.3 (CH), 75.0 (CH), 76.5 (CH), 81.1 (CH), 74.9 (CH), 68.7 (CH~2~)\] \[[@B21-molecules-24-00069]\]. In the HMBC spectrum of **5**, long-range correlations were observed between H-1′′ of Glc (II) and C-4′ of Glc (I), H-1′′′ of Glc (III) and C-6′ of Glc (I), and between H-1′ of Glc (II) and C-3 of the aglycone at δ~C~ 88.7. Thus, **5** was deduced to be (23*R*,24*R*,25*R*)-16β,23:23,26:24,25-triepoxy-28-hydroxy-9,19-cylcoartan-3β-yl *O*-β-[d]{.smallcaps}-glucopyranosyl-(1`→`4)-*O*-\[β-[d]{.smallcaps}-glucopyranosyl(1`→`6)\]-β-[d]{.smallcaps}-glucopyranoside.

Compounds **6** and **7** had the molecular formula C~42~H~64~O~15~ and C~42~H~66~O~14~, respectively, based on HR-ESI-TOF-MS and ^13^C-NMR data. The ^1^H- and ^13^C-NMR spectral properties of **6** were essentially analogous to those of **2**; however, the hydroxymethyl signals at δ~H~ 4.02 and 3.94 (each d, *J* = 11.5 Hz) and δ~C~ 63.4 assignable to H~2~-28 and C-28 in **2** were replaced by those due to an aldehyde group at δ~H~ 10.14 (s) and δ~C~ 210.2 in **6**. Treatment of **6** with NaBH~4~ in EtOH afforded **2**. On the other hand, comparison of the ^1^H- and ^13^C-NMR spectra of **7** with those **4** revealed that the H~2~-28/C-28 hydroxymethyl proton and carbon signals observed for **4** disappeared in the case of **7**. Instead, the signals from a tertiary methyl group were detected at δ~H~ 0.80 (s) and δ~C~ 19.7 in the spectrum of **7**. The methyl proton signal showed HMBC correlations with the C-8 (δ~C~ 47.5), C-13 (δ~C~ 46.3), C-14 (δ~C~ 44.7) and C-15 (δ~C~ 44.4) carbon signals. Compounds **6** and **7** were determined to be (23*R*,24*R*,25*R*)-16β,23:23,26:24,25-triepoxy-28-oxo-9,19-cycloartan-3β-yl *O*-β-[d]{.smallcaps}-glucopyranosyl-(1`→`4)-β-[d]{.smallcaps}-glucopyranoside and (23*R*,24*R*,25*R*)-16β,23:23,26:24,25-triepoxy-9,19-cycloartan-3β-yl *O*-β-[d]{.smallcaps}-glucopyranosyl-(1`→`6)-β-[d]{.smallcaps}-glucopyranoside.

Compound **8** had the same molecular formula as **2** (C~42~H~66~O~15~), and its ^1^H- and ^13^C-NMR spectral features were closely related to those of **2**, except for the signals from the ring E and F parts. Enzymatic hydrolysis of **8** gave an aglycone (**8a**; C~30~H~46~O~5~) and [d]{.smallcaps}-glucose. The phase-sensitive NOE correlation spectroscopy (PHNOESY) spectrum of **8a** showed NOE correlations between H-16 (δ~H~ 4.80) and H-22 α (δ~H~ 1.56)/H-26a (δ~H~ 3.82), H-20 (δ~H~ 1.85) and H-24 (δ~H~ 3.69), and between H-22β(δ~H~ 2.16) and H-24, indicating that **8a** was a new aglycone, the C-23 epimer of **1a**. Compound **8** was assigned as (23*S*,24*R*,25*R*)-16β,23:23,26:24,25-triepoxy-28-hydroxy-9,19-cycloartan-3β-yl *O*-β-[d]{.smallcaps}-glucopyranosyl-(1`→`4)-β-[d]{.smallcaps}-glucopyranoside.

Compounds **9** and **10** had the same molecular formula C~42~H~66~O~15~, and their ^1^H- and ^13^C-NMR spectra were suggestive of cycloartane diglucosides closely related to **8**. Indeed, enzymatic hydrolysis of **9** and **10** gave **8a** and [d]{.smallcaps}-glucose. Assignments of the ^1^H- and ^13^C-NMR signals from the sugar moieties of **9** and **10**, which were established by ^1^H-^1^H COSY and HMQC spectral analysis, implied that the diglucoside sequences of **9** and **10** corresponded to those of **3** and **4**, respectively. Furthermore, HMBC correlations were observed from H-1′′ of Glc (II) at δ~H~ 5.31 (d, *J* = 7.9 Hz) to C-3′ of Glc (I) at δ~C~ 88.9, and from H-1′ at δ~H~ 4.89 (d, *J* = 7.8 Hz) to C-3 of the aglycone at δ~C~ 88.7 in **9**, and from H-1′′ of Glc (II) at δ~H~ 5.16 (d, *J* = 7.8 Hz) to C-6′ of Glc (I) at δ~C~ 70.3, and from H-1′ at δ~H~ 4.89 (d, *J* = 7.7 Hz) to C-3 of the aglycone at δ~C~ 88.4 in **10**. Compounds **9** and **10** were formulated as *O*-β-[d]{.smallcaps}-glucopyranosyl-(1`→`3)-β-[d]{.smallcaps}-glucopyranoside and *O*-β-[d]{.smallcaps}-glucopyranosyl-(1`→`6)-β-[d]{.smallcaps}-glucopyranoside of (23*S*,24*R*,25*R*)-16β,23:23,26:24,25-triepoxy-28-hydroxy-9,19-cylcoartan-3β-yl, respectively.

Compound **11** (C~42~H~66~O~14~) bore close similarity to **10** in terms of the ^1^H- and ^13^C-NMR spectral features. However, the hydroxymethyl signals at δ~H~ 3.98 and 3.89 (each d, *J* = 11.5 Hz) and δ~C~ 63.2 assignable to H~2~-28 and C-28 in **10** were replaced by the signals due to a methyl group at δ~H~ 0.79 (s) and δ~C~ 19.6 in **11**. In addition, the methyl proton signal showed HMBC correlations with the C-8 (δ~C~ 47.6), C-13 (δ~C~ 46.3), C-14 (δ~C~ 44.5), and C-15 (δ~C~ 43.8) carbon signals. Compound **11** was established to be (23*S*,24*R*,25*R*)-16β,23:23,26:24,25-triepoxy-9,19-cycloartan-3β-yl *O*-β-[d]{.smallcaps}-glucopyranosyl-(1`→`6)-β-[d]{.smallcaps}-glucopyranoside.

Compound **13** had the molecular formula C~53~H~86~O~22~, as revealed by HR-ESI-TOF-MS (*m*/*z* 1075.5710 \[M + H\]^+^) and ^13^C-NMR (53 carbon signals) data. The molecular formula was larger than that of **12** by C~6~H~10~O~5~, which corresponded to one hexosyl unit. The ^1^H-NMR spectrum of **13** displayed signals for four anomeric protons at δ~H~ 6.02 (br s), 5.29 (d, *J* = 7.8 Hz), 5.06 (d, *J* = 7.9 Hz) and 4.92 (d, *J* = 6.9 Hz), as well as the signals for six tertiary methyl groups at δ~H~ 1.25, 1.05, 1.02, 1.00, 0.94 and 0.92 (each s), and an olefinic proton at δ~H~ 5.46 (t-like, *J* = 3.0 Hz), suggesting that this compound was a tetraglycoside of an oleanoic acid derivative. Acid hydrolysis of **13** with 1M HCl in dioxane-H~2~O (1:1) gave 23-hydroxyolean-12-en-28-oic acid (hederagenin) as the aglycone \[[@B22-molecules-24-00069]\], and [l]{.smallcaps}-arabinose, [d]{.smallcaps}-galactose, [d]{.smallcaps}-glucose and [l]{.smallcaps}-rhamnose as the carbohydrate moieties. When the ^13^C-NMR spectrum of **13** was compared with that of **12 \[[@B6-molecules-24-00069]\]**, six signals assignable to a terminal β-[d]{.smallcaps}-galactopyraosyl group (Gal) were observed in addition to signals for a 2,4-disubstituted α-[l]{.smallcaps}-arabinopyranosyl group (Ara), C-3 substituted α-[l]{.smallcaps}-rhamnopyranosyl group (Rha), and terminal β-[d]{.smallcaps}-glucopyranosyl group (Glc). The anomeric configurations of Ara, Gal and Glc were confirmed to be α, β, and β, respectively, based on the relatively large ^3^*J*~H-1,H-2~ values (6.9--7.9 Hz). In the case of the Rha moiety, the large ^1^*J*~C-1,H-1~ (172 Hz) was indicative of the α-anomeric configuration \[[@B6-molecules-24-00069]\]. In the HMBC spectrum of **13**, long-range couplings were observed between H-1′′′ of Glc (δ~H~ 5.29) and C-4′ of Ara at δ~C~ 80.0, H-1′′′′ of Gal (δ~H~ 5.06) and C-3′′ of Rha at δ~C~ 83.2, H-1′′ of Rha (δ~H~ 6.02) and C-2′ of Ara at δ~C~ 76.5, and between H-1′ of Ara (δ~H~ 4.92) and C-3 of the aglycone at δ~C~ 81.3. Compound **13** was determined to be 3 β-\[(*O*-β-[d]{.smallcaps}-galactopyranosyl-(1`→`3)-*O*-α-[l]{.smallcaps}-rhamnopyranosyl-(1`→`2)-*O*-\[β-[d]{.smallcaps}-glucopyranosyl-(1`→`4)\]-α-[l]{.smallcaps}-arabinopyranosyl)oxy\]-23-hydroxyolean-12-en-28-oic acid.

2.2. Cytotoxic Activity of ***1a***, ***2***, ***8***, ***8a***, ***12***, and ***13*** {#sec2dot2-molecules-24-00069}
---------------------------------------------------------------------------------------

We previously reported that the slight differences in the structure of cycloartane glycosides effected on cytotoxic activity \[[@B8-molecules-24-00069]\]. In this study, some selected compounds, the new cycloartane glycosides (**2** and **8**), and the aglycone (**1a**) of **2** and its C-23 epimer (**8a**), as well as oleanane glycosides (**12** and **13**) were evaluated for their cytotoxic activity against HL-60 cells using a modified 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2*H*-tetrazolium bromide (MTT) assay ([Table 2](#molecules-24-00069-t002){ref-type="table"}). Etoposide was used as a positive control, and it gave an IC~50~ value of 0.32 ± 0.01 μM. The cytotoxic activity of **8a** against HL-60 cells (IC~50~ 14.8 ± 1.00 μM) was much more potent than that of **1a** (IC~50~ 101.1 ± 0.44 μM), indicating that the C-23 configuration is associated with the cytotoxicity of these cycloartane derivatives. On the other hand, **2** and **8** were not cytotoxic to HL-60 cells at sample concentrations up to 200 μM. Compounds **12** and **13** were cytotoxic to HL-60 cells, with IC~50~ values of 10.6 ± 0.40 μM and 10.8 ± 0.53 μM, respectively. After HL-60 cells were exposed to **12** at a sample concentration of 20 μM for 72 h, they were stained with 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) and observed under a fluorescence microscope. The cells showed nuclear chromatin condensation and nuclear disassembly, illustrated in [Figure 3](#molecules-24-00069-f003){ref-type="fig"}. Therefore, **12** partially induced apoptotic cell death in HL-60 cells.

3. Materials and Methods {#sec3-molecules-24-00069}
========================

3.1. General Experimental Procedures and Plant Material {#sec3dot1-molecules-24-00069}
-------------------------------------------------------

The instruments, experimental conditions, and plant material used (except for those mentioned below) were the same as those described in previous papers \[[@B18-molecules-24-00069],[@B19-molecules-24-00069]\]. Melting point was determined on an MP-3 melting point apparatus (Yanaco, Kyoto, Japan). X-ray diffraction experiments were carried out on a DIP image plate diffractometer (Bruker AXS, Karlsruhe, Germany).

3.2. Extraction and Isolation {#sec3dot2-molecules-24-00069}
-----------------------------

The MeOH extract (135 g) of *Eranthis cilicica* tubers (1.3 kg) was subjected to Diaion HP-20 CC \[[@B19-molecules-24-00069]\]. The 80% MeOH eluted portion (30 g) was chromatographed on silica gel eluted with gradient mixtures of CHCl~3~-MeOH (20:1; 9:1, 4:1, 2:1) and finally with MeOH to give 9 subfractions (Frs. A--I). Fr. E was subjected silica gel CC eluted with CHCl~3~-MeOH (9:1) and ODS silica gel CC eluted with MeCN-H~2~O (1:2) to yield **1** (17.0 mg) and **7** (13.4 mg). Fr. G was repeatedly subjected to silica gel CC eluted with CHCl~3~-MeOH-H~2~O (60:10:1, 50:10:1, 40:10:1) and ODS silica gel CC eluted with MeCN-H~2~O (5:8, 5:9, 1:2) to yield **2** (121 mg), **3** (7.8 mg), **8** (100 mg), **9** (4.1 mg), **10** (35.0 mg), and **11** (5.1 mg). Fr. H was subjected to CC on silica gel eluted with CHCl~3~-MeOH-H~2~O (30:10:1) and ODS silica gel eluted with MeCN-H~2~O (1:2) and MeOH-H~2~O (7:5) to yield **13** (15.2 mg). Fr. I was subjected to CC on silica gel eluted with CHCl~3~-MeOH-H~2~O (14:8:1; 10:10:1) and ODS silica gel eluted with MeCN-H~2~O (5:8, 2:5, 4:11, 1:3) to yield **12** (13.7 mg). The 50% MeOH eluted portion (35 g) was chromatographed on silica gel eluted with CHCl~3~-MeOH-H~2~O (40:10:1) to give 6 subfractions (Frs. a--f). Fr. b was subjected to silica gel column eluted with CHCl~3~-MeOH (20:1) and CHCl~3~-MeOH-H~2~O (40:10:1) and ODS silica gel column eluted with MeCN-H~2~O (1:2, 2:5, 1:3) to yield **4** (15.2 mg) and **6** (10.0 mg). Fr. c was subjected to silica gel CC eluted with CHCl~3~-MeOH (10:1) and CHCl~3~-MeOH-H~2~O (40:10:1) and ODS silica gel CC eluted with MeCN-H~2~O (1:2) to yield **5** (33.8 mg).

3.3. Structural Characterization {#sec3dot3-molecules-24-00069}
--------------------------------

Compound **1**: Amorphous solid. \[α\]~D~^25^ −46.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 671.3794 \[M + Na\]^+^ (Calcd for C~36~H~56~NaO~10~, 671.3771). IR ν~max~ (film) cm^−1^: 3388 (OH), 2928 and 2870 (CH). ^1^H-NMR spectral data for **1** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Enzymatic Hydrolysis of **1** Compound **1** (4.5 mg) was treated with naringinase (EC 232-96-4, Sigma; 22.5 mg) in a mixture of HOAc/KOAc buffer (pH 4.3, 5 mL) and EtOH (2 mL) at room temperature for 72 h. The reaction mixture was purified by silica gel CC eluted with CHCl~3~-MeOH (22:1) followed by MeOH to give **1a** (2.4 mg) and a sugar fraction (0.6 mg). The sugar fraction was analyzed by HPLC under the following conditions: Capcell Pak NH~2~ UG80 column (4.6 mm i.d. × 250 mm, 5 μm, Shiseido, Tokyo, Japan); mobile phase of MeCN-H~2~O (7:3); detection by refractive index and optical rotation, and at a flow rate of 1.0 mL/min. [d]{.smallcaps}-glucose was identified by comparing its retention time and optical rotation with those of an authentic sample; *t*~R~ 11.62 min ([d]{.smallcaps}-glucose, positive optical rotation).

Compound **1a**: Colorless needles from MeOH-MeCN (1:1). mp 281--285 °C. \[α\]~D~^24^ −48.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 509.3255 \[M + Na\]^+^ (Calcd for C~30~H~46~NaO~5~, 509.3243). IR ν~max~ (film) cm^−1^: 3476 (OH), 2953, 2925 and 2868 (CH). ^1^H-NMR spectral data for **1a** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

X-Ray Crystallography of **1a** Monoclinic, space group *C*2, unit cell dimension *a* = 32.945(2) Å, *b* = 6.9250(2) Å, *c* = 13.5690(6), β = 111.270(2)°, *V* = 2884.8(2) Å^3^, *Z* = 4; *T* = 296 K, *d*~calc~ = 1.204 Mg/m^3^; μ (Mo Kα, λ = 0.71073 Å) = 0.084 mm^−1^; *R* \[*I* \> 2σ(*I*)\] = 0.0370, *wR* \[*I* \> 2σ(*I*)\] = 0.1054, *R* \[for all data\] = 0.0409, *wR* \[for all data\] = 0.1081. Crystallographic data of **1a** have been deposited with the Cambridge Crystallographic Data Centre (CCDC) as supplementary publication no. CCDC 1877743. Copies of the data can be obtained free of charge from the CCDC via <http://beta-www.ccdc.cam.ac.uk>.

Compound **2**: Amorphous solid. \[α\]~D~^26^ −34.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 833.4297 \[M + Na\]^+^ (Calcd for C~42~H~66~NaO~15~, 833.4299). IR ν~max~ (film) cm^−1^: 3397 (OH), 2930 and 2870 (CH). ^1^H-NMR spectral data for **2** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Compound **3**: Amorphous solid. \[α\]~D~^24^ −48.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 833.4359 \[M + Na\]^+^ (Calcd for C~42~H~66~NaO~15~, 833.4299). IR ν~max~ (film) cm^−1^: 3450 (OH), 2932 and 2872 (CH). ^1^H-NMR spectral data for **3** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Compound **4**: Amorphous solid. \[α\]~D~^26^ −44.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 833.4340 \[M + Na\]^+^ (Calcd for C~42~H~66~NaO~15~, 833.4299). IR ν~max~ (film) cm^−1^: 3408 (OH), 2933 and 2871 (CH). ^1^H-NMR spectral data for **4** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Compound **5**: Amorphous solid. \[α\]~D~^28^ −16.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 973.5001 \[M + H\]^+^ (Calcd for C~48~H~77~O~20~, 973.5008). IR ν~max~ (film) cm^−1^: 3363 (OH), 2932 and 2872 (CH). ^1^H-NMR spectral data for **5** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Enzymatic Hydrolysis of **2**--**5** Compounds **2** (54.1 mg), **3** (2.5 mg), **4** (5.1 mg), and **5** (4.8 mg) were independently subjected to enzymatic hydrolysis with naringinase as described for **1** to give **1a** (25.2 mg from **2**; 1.3 mg from **3**; 2.5 mg from **4**; 2.6 mg from **5**) and a sugar fraction (5.9 mg from **2**; 0.4 mg from **3**; 0.8 mg from **4**; 1.2 mg from **5**). HPLC analysis of the sugar fraction under the same conditions as in the case of that of **1** showed the presence of [d]{.smallcaps}-glucose.

Compound **6**: Amorphous solid. \[α\]~D~^24^ −84.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 831.4100 \[M + Na\]^+^ (Calcd for C~42~H~64~NaO~15~, 831.4143). IR ν~max~ (film) cm^−1^: 3387 (OH), 2925 and 2870 (CH), 1712 (C=O). ^1^H-NMR spectral data for **6** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Preparation of **2** from **6** Compound **6** (1.7 mg) was dissolved in NaBH~4~ (2.2 mg) ethanolic solution (1 mL) and it was stirred at room temperature for 5 h. After Me~2~CO was added to the reaction mixture, the solvent was removed under reduced pressure. The residue was suspended with H~2~O (3 mL) and extracted with EtOAc (3 mL × 3). The EtOAc extract was chromatographed on silica gel eluted with CHCl~3~-MeOH-H~2~O (30:10:1) to yield **2** (1.2 mg).

Compound **7**: Amorphous solid. \[α\]~D~^25^ −70.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 817.4393 \[M + Na\]^+^ (Calcd for C~42~H~66~NaO~14~, 817.4350). IR ν~max~ (film) cm^−1^: 3418 (OH), 2931 and 2868 (CH). ^1^H-NMR spectral data for **7** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Compound **8**: Amorphous solid. \[α\]~D~^26^ −50.0 (*c* 0.10, C~5~H~5~N). HR-ESI-TOF-MS *m*/*z*: 833.4359 \[M + Na\]^+^ (Calcd for C~42~H~66~NaO~15~, 833.4299). IR ν~max~ (film) cm^−1^: 3348 (OH), 2926 and 2867 (CH). ^1^H-NMR spectral data for **8** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Compound **8a**: Amorphous solid. \[α\]~D~^24^ −58.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 487.3423 \[M + H\]^+^ (Calcd for C~30~H~47~O~5~, 487.3424). IR ν~max~ (film) cm^−1^: 3442 (OH), 2955, 2927 and 2870 (CH). ^1^H-NMR spectral data for **8a** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Compound **9**: Amorphous solid. \[α\]~D~^26^ −36.0 (*c* 0.10, C~5~H~5~N). HR-ESI-TOF-MS *m*/*z*: 833.4276 \[M + Na\]^+^ (Calcd for C~42~H~66~NaO~15~, 833.4299). IR ν~max~ (film) cm^−1^: 3347 (OH), 2919 and 2871 (CH). ^1^H-NMR spectral data for **9** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Compound **10**: Amorphous solid. \[α\]~D~^26^ −72.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 833.4313 \[M + Na\]^+^ (Calcd for C~42~H~66~NaO~15~, 833.4299). IR ν~max~ (film) cm^−1^: 3388 (OH), 2933 and 2872 (CH). ^1^H-NMR spectral data for **10** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Enzymatic Hydrolysis of **8**--**10** Compounds **8** (31.3 mg), **9** (1.9 mg), and **10** (5.3 mg) were independently subjected to enzymatic hydrolysis with naringinase as described for **1** to give **8a** (19.4 mg from **8**; 0.9 mg from **9**; 2.8 mg from **10**) and a sugar fraction (3.2 mg from **8**; 0.3 mg from **9**; 1.1 mg from **10**). HPLC analysis of the sugar fraction under the same conditions as in the case of that of **1** showed the presence of [d]{.smallcaps}-glucose.

Compound **11**: Amorphous solid. \[α\]~D~^26^ −62.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 795.4583 \[M + H\]^+^ (Calcd for C~42~H~67~O~14~, 795.4531). IR ν~max~ (film) cm^−1^: 3387 (OH), 2927 and 2871 (CH). ^1^H-NMR spectral data for **11** are provided in the [Supplementary Materials](#app1-molecules-24-00069){ref-type="app"}. ^13^C-NMR, see [Table 1](#molecules-24-00069-t001){ref-type="table"}.

Compound **13**: Amorphous solid. \[α\]~D~^27^ +6.0 (*c* 0.10, MeOH). HR-ESI-TOF-MS *m*/*z*: 1075.5710 \[M + H\]^+^ (Calcd for C~53~H~87~O~22~, 1075.5689). IR ν~max~ (film) cm^−1^: 3376 (OH), 2926 and 2858 (CH), 1696 (C=O). ^1^H-NMR (C~5~D~5~N) δ~H~ 6.02 (1H, br s, H-1′′), 5.46 (1H, t-like, *J* = 3.0 Hz, H-12), 5.29 (1H, d, *J* = 7.8 Hz, H-1′′′), 5.06 (1H, d, *J* = 7.9 Hz, H-1′′′′), 4.92 (1H, d, *J* = 6.9 Hz, H-1′), 4.48 (1H, dd, *J* = 9.3, 7.8 Hz, H-2′′′), 4.46 (1H, br s, H-4′′′), 4.36 (1H, m, H-6a′′′), 4.34 (1H, m, H-6b′′′), 4.24 (1H, d, *J* = 11.0 Hz, H-23a), 4.18 (1H, dd, *J* = 10.5, 4.6 Hz, H-3), 4.10 (1H, dd, *J* = 9.3, 3.3 Hz, H-3′′′), 4.07 (1H, m, H-5′′′), 3.86 (1H, d, *J* = 11.0 Hz, H-23b), 3.26 (1H, dd, *J* = 13.8, 3.9 Hz, H-18), 1.54 (3H, d, *J* = 6.1 Hz, Me-6′′), 1.25 (3H, s, Me-27), 1.05 (3H, s, Me-24), 1.02 (3H, s, Me-26), 1.00 (3H, s, Me-30), 0.94 (3H, s, Me-25), 0.92 (3H, s, Me-29). ^13^C-NMR (C~5~D~5~N) δ~C~: 39.0, 26.3, 81.3, 43.5, 47.6, 18.2, 32.9, 39.8, 48.2, 36.9, 23.8, 122.6, 144.8, 42.2, 28.3, 23.7, 46.7, 42.0, 46.5, 30.9, 34.2, 32.0, 64.0, 13.9, 16.0, 17.5, 26.1, 180.1, 33.2, 23.8 (aglycone C-1--C-30), 104.7, 76.5, 74.2, 80.0, 65.5 (Ara C-1--C-5), 101.6, 71.2, 83.2, 72.6, 69.9, 18.5 (Rha C-1--C-6), 107.1, 73.3, 75.2, 70.0, 76.8, 62.1 (Gal C-1--C-6), 106.5, 75.5, 78.3, 71.4, 78.5, 62.5 (Glc C-1--C-6).

Acid Hydrolysis of **13** A solution of **13** (5.0 mg) in 1 M HCl (dioxane-H~2~O, 1:1, 3 mL) was heated at 95 °C for 1 h under an Ar atmosphere. After the reaction mixture was diluted with H~2~O (2 mL), it was extracted with Et~2~O (5 mL × 2). The Et~2~O extract was chromatographed on silica gel eluted with CHCl~3~-MeOH (19:1) to give hederagenin (2.6 mg). The H~2~O residue was neutralized using an Amberlite IRA-93ZU (Organo, Tokyo, Japan) column and passed through a Sep-Pak C~18~ cartridge (Waters, Milford, MA) eluted with H~2~O-MeOH (3:2) to give a sugar fraction (1.8 mg). HPLC analysis of the sugar fraction under the same conditions as in the case of that of **1** (flow rate, 0.9 mL/min) showed the presence of [l]{.smallcaps}-arabinose, [d]{.smallcaps}-galactose, [d]{.smallcaps}-glucose, and [l]{.smallcaps}-rhamnose. *t*~R~ (min): 7.08 (negative optical rotation, [l]{.smallcaps}-rhamnose), 8.14 (positive optical rotation, [l]{.smallcaps}-arabinose), 12.86 (positive optical rotation, [d]{.smallcaps}-galactose), and 13.17 (positive optical rotation, [d]{.smallcaps}-glucose).

3.4. Cytotoxic Activity {#sec3dot4-molecules-24-00069}
-----------------------

HL-60 cells were maintained in an RPMI-1640 medium. The cell media contained heat-inactivated 10% (*v/v*) FBS supplemented with [l]{.smallcaps}-glutamine, penicillin G sodium salt (100 units/mL), and streptomycin sulfate (100 μg/mL). HL-60 (4 × 10^4^ cells/mL) cells were continuously treated with each compound for 72 h, and cell growth was measured using an MTT reduction assay as previously described \[[@B23-molecules-24-00069]\]. Data represented as mean ± S.E.M. of three experiments performed in triplicate. The concentration, resulting in a 50% inhibition value (IC~50~), was calculated from the dose response curve.

3.5. DAPI Staininig {#sec3dot5-molecules-24-00069}
-------------------

The cells (1 × 10^5^ cells/mL) were plated on coverslips in 96-well plates. After 24 h, HL-60 cells were treated with either 20 μM of **12** or 17 μM of etoposide for 72 h. The cells were fixed with 1% glutaraldehyde for 30 min at room temperature before staining with DAPI (0.5 μg/mL in H~2~O). They were observed under a CKX41 fluoroscence microscope (Olympus, Tokyo, Japan).

4. Conclusions {#sec4-molecules-24-00069}
==============

Further phytochemical examination of *E. cilicica* tubers gave eleven new cycloartane glycosides (**1**--**11**) and one new oleanane glycoside (**13**), together with one known oleanane glycosides (**12**). The structures of the new compounds were established by extensive spectroscopic analysis, including 2D NMR, and enzymatic hydrolysis, followed by either X-ray crystallographic or chromatographic analysis. The new cycloartane glycosides **2** and **8**, the aglycone **1a** and its C-23 epimer **8a**, and oleanane-type triterpene glycosides **12** and **13** were evaluated for their cytotoxic activity against HL-60 leukemia cells. The cytotoxic activity of **8a** was much more potent than that of **1a**, indicating that the C-23 configuration is associated with the cytotoxicity of these cycloartane derivatives. This is the first report of structure--activity relationships of cycloartane-type triterpenoids on C-23 epimer. Compounds **12** and **13** were moderately cytotoxic to HL-60 cells, and **12** partially induced apoptotic cell death in HL-60 cells.
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![Structures of **1**, **1a**, **2**--**8**, **8a**, and **9**--**13.**](molecules-24-00069-g001){#molecules-24-00069-f001}
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![Morphology of HL-60 cells treated with either etoposide or **12**. HL-60 cells were incubated with either etoposide (17 μM) or **12** (20 μM) for 72 h, stained with DAPI and observed under a fluorescence microscope (magnification, 200×).](molecules-24-00069-g003){#molecules-24-00069-f003}
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###### 

^13^C-NMR spectral data for **1**, **1a**, **2**--**8**, **8a**, and **9**--**11** in C~5~D~5~N.

  C      1       1a      2       3       4       5       6       7       8       8a      9       10      11
  ------ ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- -------
  1      32.1    32.5    32.1    32.0    32.1    32.0    31.3    32.1    32.1    32.4    32.1    32.1    32.0
  2      29.8    31.2    29.7    29.6    29.9    29.7    29.5    30.2    29.8    31.1    29.8    30.0    29.9
  3      88.6    77.9    88.7    88.6    88.4    88.7    88.3    88.5    88.7    77.8    88.7    88.4    88.5
  4      41.2    41.0    41.1    41.0    41.1    41.1    41.0    41.2    41.2    41.0    41.2    41.2    41.1
  5      47.5    47.5    47.5    47.4    47.3    47.4    46.4    47.3    47.5    47.4    47.5    47.4    47.2
  6      21.1    21.5    21.1    21.0    21.1    21.0    20.0    20.8    21.2    21.5    21.2    21.2    20.8
  7      27.4    27.6    27.4    27.3    27.4    27.4    26.7    26.2    27.5    27.6    27.5    27.5    26.2
  8      48.3    48.5    48.3    48.3    48.4    48.3    41.9    47.5    48.5    48.7    48.5    48.5    47.6
  9      19.7    19.8    19.8    19.7    19.7    19.7    19.4    19.6    19.8    19.8    19.8    19.8    19.5
  10     26.6    27.0    26.6    26.5    26.5    26.5    27.6    26.5    26.7    26.9    26.6    26.7    26.5
  11     27.3    27.4    27.2    27.2    27.1    27.1    27.6    26.3    27.2    27.2    27.2    27.1    26.1
  12     32.6    32.7    32.6    32.5    32.5    32.5    33.6    33.2    32.6    32.6    32.6    32.6    33.1
  13     45.5    45.5    45.4    45.4    45.4    45.4    46.5    46.3    45.3    45.3    45.3    45.3    46.3
  14     51.5    51.6    51.5    51.5    51.5    51.5    64.0    44.7    51.6    51.6    51.6    51.6    44.5
  15     38.2    38.3    38.2    38.1    38.1    38.1    36.1    44.4    37.6    37.6    37.6    37.6    43.8
  16     75.3    75.4    75.3    75.2    75.3    75.3    74.2    75.2    73.7    73.7    73.7    73.7    73.1
  17     56.9    57.0    56.9    56.7    56.8    56.8    57.1    56.6    57.1    57.1    57.1    57.1    56.7
  18     22.0    22.1    22.0    21.9    22.0    22.0    20.5    20.6    22.0    22.0    22.0    22.0    20.5
  19     30.6    30.9    30.6    30.5    30.6    30.5    28.1    30.0    30.6    30.8    30.6    30.7    30.1
  20     23.9    23.9    23.9    23.8    23.8    23.8    23.1    23.7    26.5    26.4    26.5    26.4    26.2
  21     20.7    20.7    20.7    20.6    20.6    20.6    20.9    20.7    20.5    20.4    20.5    20.4    20.3
  22     37.7    37.8    37.7    37.6    37.6    37.6    36.8    37.6    36.8    36.7    36.8    36.7    36.5
  23     106.1   106.1   106.1   106.0   106.1   106.1   106.2   106.1   106.1   106.1   106.1   106.1   106.0
  24     62.0    62.1    62.0    62.0    62.0    62.0    62.1    62.0    63.4    63.4    63.4    63.4    63.3
  25     62.4    62.4    62.4    62.4    62.4    62.4    62.4    62.5    63.1    63.1    63.1    63.1    63.1
  26     67.9    68.0    67.9    67.9    67.9    67.9    68.1    68.0    68.7    68.6    68.7    68.6    68.6
  27     14.2    14.2    14.2    14.1    14.2    14.1    14.2    14.2    13.7    13.7    13.7    13.7    13.7
  28     63.5    63.6    63.4    63.3    63.4    63.3    210.2   19.7    63.2    63.2    63.2    63.2    19.6
  29     25.7    26.1    25.6    25.5    25.5    25.5    25.6    25.7    25.7    26.0    25.6    25.6    25.6
  30     15.4    14.8    15.4    15.3    15.3    15.3    15.1    15.4    15.4    14.8    15.4    15.4    15.3
  1′     106.8           106.4   106.1   106.6   106.3   106.4   106.8   106.4           106.2   106.7   106.6
  2′     75.8            75.2    74.4    75.5    75.0    75.3    75.6    75.3            74.4    75.6    75.5
  3′     78.7            76.9    88.7    78.2    76.5    77.0    78.5    76.9            88.9    78.5    78.5
  4′     71.8            81.6    69.7    71.6    81.1    81.6    71.7    81.6            69.8    71.6    71.6
  5′     78.3            76.2    77.7    77.0    74.9    76.3    77.1    76.2            77.9    77.1    77.0
  6′     63.0            62.3    62.4    70.2    68.7    62.4    70.3    62.4            62.5    70.3    70.1
  1′′                    104.9   105.7   105.2   104.7   105.0   105.4   105.0           105.9   105.3   105.2
  2′′                    74.8    75.4    75.1    75.1    74.8    74.7    74.8            75.5    75.2    75.1
  3′′                    78.2    78.1    78.4    78.2    78.2    78.4    78.2            78.2    78.3    78.2
  4′′                    71.5    71.4    71.6    71.6    71.5    71.7    71.5            71.6    71.7    71.5
  5′′                    78.4    78.6    78.3    78.1    78.5    78.4    78.4            78.7    78.4    78.3
  6′′                    62.3    62.3    62.5    62.3    62.5    62.7    62.4            62.5    62.6    62.5
  1′′′                                           105.0                                                   
  2′′′                                           75.1                                                    
  3′′′                                           78.2                                                    
  4′′′                                           71.5                                                    
  5′′′                                           78.1                                                    
  6′′′                                           62.5                                                    
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###### 

Cytotoxic activity of **1a**, **2**, **8**, **8a**, **12**, **13**, and etoposide against HL-60 cells ^a^.

  Compound    IC~50~ (µM)
  ----------- --------------
  **1a**      101.1 ± 0.44
  **2**       \>200
  **8**       \>200
  **8a**      14.8 ± 1.00
  **12**      10.6 ± 0.40
  **13**      10.8 ± 0.53
  etoposide   0.32 ± 0.01

^a^ Data represent the mean value ± standard error of the mean (SEM) of three experiments performed in triplicate.
